Human Chorionic Gonadotropin (hCG) Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Human Chorionic Gonadotropin (hCG) Market to 2027 - Global Analysis and Forecasts by Technology (Natural Source Extraction, Recombinant Technology); Therapeutic Area (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment, Others); End User (Fertility Clinics, Research Institutions, Others) and Geography

Report Code: TIPRE00004577 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Human chorionic gonadotropin also known as hCG. This hormone plays a different role in both male & female sexual development. In female, the hCG mostly used to identify defect and confirm pregnancy and it is made from placenta during pregnancy which nourishes the egg after it has been fertilize. In male, especially young boys it used to increase sperm count. The hCG is administrated in body through the injection under skin into muscle. The human chorionic gonadotropin level can be Identify with the help of blood and urine test.

MARKET DYNAMICS
The human chorionic gonadotropin (hCG) market is expected to grow during the forecast period due to changing life style and increase stress level in life which affects the fertility related disease, rising incidences of male hypogondism among the geriatric population are major key driving factors of the human chronic gonadotropin market. Raising the demands and availability of infertility treatment are likely to create growth opportunities during forecast period.

MARKET SCOPE
The "Global Human Chorionic Gonadotropin (hCG) Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of the human chorionic gonadotropin (hCG) market with detailed market segmentation by test, product type, end users, distribution channels and geography. The global human chorionic gonadotropin (hCG) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading human chorionic gonadotropin (hCG) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global human chorionic gonadotropin (hCG) market is segmented on the basis of technology, therapeutic area type and end user's. On the basis of technology type the market is segmented into natural source extraction technology and recombinant technology. Based on therapeutic area type, the market is segmented as female infertility treatment, male hypogonadism and oligospermic treatment. Based on end user' market is segmented into fertility clinics, research insitute and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global human chorionic gonadotropin (hCG) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. human chorionic gonadotropin (hCG) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting human chorionic gonadotropin (hCG) market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the human chorionic gonadotropin (hCG) market in these regions.

MARKET PLAYERS
The reports cover key developments in human chorionic gonadotropin (hCG) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from the Global human chorionic gonadotropin (hCG) market are anticipated to lucrative growth opportunities in the future with the rising demand for The human chorionic gonadotropin (hCG) market in the global market. Below mentioned is the list of few companies engaged in the global human chorionic gonadotropin (hCG) market.

The report also includes the profiles of key human chorionic gonadotropin (hCG) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Merck & Co, Inc
  • Ferring B.V
  • Fresenius Kabi AG
  • Cigna
  • Sun Pharmaceutical Industries Ltd
  • Lee BioSolutions Inc
  • Sanzyme
  • Scrippslabs
  • Lupin AB
  • Prospec-Tany Technogene Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Human Chorionic Gonadotropin (hCG) Market - By Technology
1.3.2 Human Chorionic Gonadotropin (hCG) Market - By Therapeutic Area
1.3.3 Human Chorionic Gonadotropin (hCG) Market - By End User
1.3.4 Human Chorionic Gonadotropin (hCG) Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET - GLOBAL MARKET ANALYSIS
6.1. HUMAN CHORIONIC GONADOTROPIN (HCG) - GLOBAL MARKET OVERVIEW
6.2. HUMAN CHORIONIC GONADOTROPIN (HCG) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET - REVENUE AND FORECASTS TO 2027 -TECHNOLOGY
7.1. OVERVIEW
7.2. BY TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. NATURAL SOURCE EXTRACTION
7.3.1. Overview
7.3.2. Natural Source Extraction Market Forecast and Analysis
7.4. RECOMBINANT TECHNOLOGY
7.4.1. Overview
7.4.2. Recombinant Technology Market Forecast and Analysis
8. HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET - REVENUE AND FORECASTS TO 2027 -THERAPEUTIC AREA
8.1. OVERVIEW
8.2. BY THERAPEUTIC AREA MARKET FORECASTS AND ANALYSIS
8.3. FEMALE INFERTILITY TREATMENT
8.3.1. Overview
8.3.2. Female Infertility Treatment Market Forecast and Analysis
8.4. MALE HYPOGONADISM
8.4.1. Overview
8.4.2. Male Hypogonadism Market Forecast and Analysis
8.5. OLIGOSPERMIC TREATMENT
8.5.1. Overview
8.5.2. Oligospermic Treatment Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET - REVENUE AND FORECASTS TO 2027 -END USER
9.1. OVERVIEW
9.2. BY END USER MARKET FORECASTS AND ANALYSIS
9.3. FERTILITY CLINICS
9.3.1. Overview
9.3.2. Fertility Clinics Market Forecast and Analysis
9.4. RESEARCH INSTITUTIONS
9.4.1. Overview
9.4.2. Research Institutions Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Human Chorionic Gonadotropin (hCG) Market Overview
10.1.2 North America Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis
10.1.3 North America Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Technology
10.1.4 North America Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Therapeutic Area
10.1.5 North America Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By End User
10.1.6 North America Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Countries
10.1.6.1 United States Human Chorionic Gonadotropin (hCG) Market
10.1.6.1.1 United States Human Chorionic Gonadotropin (hCG) Market By Technology
10.1.6.1.2 United States Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.1.6.1.3 United States Human Chorionic Gonadotropin (hCG) Market By End User
10.1.6.2 Canada Human Chorionic Gonadotropin (hCG) Market
10.1.6.2.1 Canada Human Chorionic Gonadotropin (hCG) Market By Technology
10.1.6.2.2 Canada Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.1.6.2.3 Canada Human Chorionic Gonadotropin (hCG) Market By End User
10.1.6.3 Mexico Human Chorionic Gonadotropin (hCG) Market
10.1.6.3.1 Mexico Human Chorionic Gonadotropin (hCG) Market By Technology
10.1.6.3.2 Mexico Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.1.6.3.3 Mexico Human Chorionic Gonadotropin (hCG) Market By End User
10.2. EUROPE
10.2.1 Europe Human Chorionic Gonadotropin (hCG) Market Overview
10.2.2 Europe Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis
10.2.3 Europe Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Technology
10.2.4 Europe Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Therapeutic Area
10.2.5 Europe Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By End User
10.2.6 Europe Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Human Chorionic Gonadotropin (hCG) Market
10.2.6.1.1 Germany Human Chorionic Gonadotropin (hCG) Market By Technology
10.2.6.1.2 Germany Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.2.6.1.3 Germany Human Chorionic Gonadotropin (hCG) Market By End User
10.2.6.2 France Human Chorionic Gonadotropin (hCG) Market
10.2.6.2.1 France Human Chorionic Gonadotropin (hCG) Market By Technology
10.2.6.2.2 France Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.2.6.2.3 France Human Chorionic Gonadotropin (hCG) Market By End User
10.2.6.3 Italy Human Chorionic Gonadotropin (hCG) Market
10.2.6.3.1 Italy Human Chorionic Gonadotropin (hCG) Market By Technology
10.2.6.3.2 Italy Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.2.6.3.3 Italy Human Chorionic Gonadotropin (hCG) Market By End User
10.2.6.4 Spain Human Chorionic Gonadotropin (hCG) Market
10.2.6.4.1 Spain Human Chorionic Gonadotropin (hCG) Market By Technology
10.2.6.4.2 Spain Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.2.6.4.3 Spain Human Chorionic Gonadotropin (hCG) Market By End User
10.2.6.5 United Kingdom Human Chorionic Gonadotropin (hCG) Market
10.2.6.5.1 United Kingdom Human Chorionic Gonadotropin (hCG) Market By Technology
10.2.6.5.2 United Kingdom Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.2.6.5.3 United Kingdom Human Chorionic Gonadotropin (hCG) Market By End User
10.2.6.6 Rest of Europe Human Chorionic Gonadotropin (hCG) Market
10.2.6.6.1 Rest of Europe Human Chorionic Gonadotropin (hCG) Market By Technology
10.2.6.6.2 Rest of Europe Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.2.6.6.3 Rest of Europe Human Chorionic Gonadotropin (hCG) Market By End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Overview
10.3.2 Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis
10.3.3 Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Therapeutic Area
10.3.5 Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Human Chorionic Gonadotropin (hCG) Market
10.3.6.1.1 Australia Human Chorionic Gonadotropin (hCG) Market By Technology
10.3.6.1.2 Australia Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.3.6.1.3 Australia Human Chorionic Gonadotropin (hCG) Market By End User
10.3.6.2 China Human Chorionic Gonadotropin (hCG) Market
10.3.6.2.1 China Human Chorionic Gonadotropin (hCG) Market By Technology
10.3.6.2.2 China Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.3.6.2.3 China Human Chorionic Gonadotropin (hCG) Market By End User
10.3.6.3 India Human Chorionic Gonadotropin (hCG) Market
10.3.6.3.1 India Human Chorionic Gonadotropin (hCG) Market By Technology
10.3.6.3.2 India Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.3.6.3.3 India Human Chorionic Gonadotropin (hCG) Market By End User
10.3.6.4 Japan Human Chorionic Gonadotropin (hCG) Market
10.3.6.4.1 Japan Human Chorionic Gonadotropin (hCG) Market By Technology
10.3.6.4.2 Japan Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.3.6.4.3 Japan Human Chorionic Gonadotropin (hCG) Market By End User
10.3.6.5 South Korea Human Chorionic Gonadotropin (hCG) Market
10.3.6.5.1 South Korea Human Chorionic Gonadotropin (hCG) Market By Technology
10.3.6.5.2 South Korea Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.3.6.5.3 South Korea Human Chorionic Gonadotropin (hCG) Market By End User
10.3.6.6 Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Market
10.3.6.6.1 Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Market By Technology
10.3.6.6.2 Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.3.6.6.3 Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Market By End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Human Chorionic Gonadotropin (hCG) Market Overview
10.4.2 Middle East and Africa Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis
10.4.3 Middle East and Africa Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Therapeutic Area
10.4.5 Middle East and Africa Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Human Chorionic Gonadotropin (hCG) Market
10.4.6.1.1 South Africa Human Chorionic Gonadotropin (hCG) Market By Technology
10.4.6.1.2 South Africa Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.4.6.1.3 South Africa Human Chorionic Gonadotropin (hCG) Market By End User
10.4.6.2 Saudi Arabia Human Chorionic Gonadotropin (hCG) Market
10.4.6.2.1 Saudi Arabia Human Chorionic Gonadotropin (hCG) Market By Technology
10.4.6.2.2 Saudi Arabia Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.4.6.2.3 Saudi Arabia Human Chorionic Gonadotropin (hCG) Market By End User
10.4.6.3 U.A.E Human Chorionic Gonadotropin (hCG) Market
10.4.6.3.1 U.A.E Human Chorionic Gonadotropin (hCG) Market By Technology
10.4.6.3.2 U.A.E Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.4.6.3.3 U.A.E Human Chorionic Gonadotropin (hCG) Market By End User
10.4.6.4 Rest of Middle East and Africa Human Chorionic Gonadotropin (hCG) Market
10.4.6.4.1 Rest of Middle East and Africa Human Chorionic Gonadotropin (hCG) Market By Technology
10.4.6.4.2 Rest of Middle East and Africa Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.4.6.4.3 Rest of Middle East and Africa Human Chorionic Gonadotropin (hCG) Market By End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Human Chorionic Gonadotropin (hCG) Market Overview
10.5.2 South and Central America Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis
10.5.3 South and Central America Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Therapeutic Area
10.5.5 South and Central America Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By End User
10.5.6 South and Central America Human Chorionic Gonadotropin (hCG) Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Human Chorionic Gonadotropin (hCG) Market
10.5.6.1.1 Brazil Human Chorionic Gonadotropin (hCG) Market By Technology
10.5.6.1.2 Brazil Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.5.6.1.3 Brazil Human Chorionic Gonadotropin (hCG) Market By End User
10.5.6.2 Argentina Human Chorionic Gonadotropin (hCG) Market
10.5.6.2.1 Argentina Human Chorionic Gonadotropin (hCG) Market By Technology
10.5.6.2.2 Argentina Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.5.6.2.3 Argentina Human Chorionic Gonadotropin (hCG) Market By End User
10.5.6.3 Rest of South and Central America Human Chorionic Gonadotropin (hCG) Market
10.5.6.3.1 Rest of South and Central America Human Chorionic Gonadotropin (hCG) Market By Technology
10.5.6.3.2 Rest of South and Central America Human Chorionic Gonadotropin (hCG) Market By Therapeutic Area
10.5.6.3.3 Rest of South and Central America Human Chorionic Gonadotropin (hCG) Market By End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, KEY COMPANY PROFILES
12.1. MERCK & CO, INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. FERRING B.V
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FRESENIUS KABI AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CIGNA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SUN PHARMACEUTICAL INDUSTRIES LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LEE BIOSOLUTIONS INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANZYME
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SCRIPPS LABORATORIES
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. LUPIN AB
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PROSPEC-TANY TECHNOGENE LTD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Merck & Co, Inc
2. Ferring B. V
3. Fresenius Kabi AG
4. Cigna
5. Sun Pharmaceutical Industries Ltd
6. Lee BioSolutions Inc
7. Sanzyme
8. Scrippslabs
9. Lupin AB
10. Prospec-Tany Technogene Ltd
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book